Experimental Drugs Offer New Hope for Patients Fighting Melanoma

An experimental drug uses the body's immune system to help target tumor cells in patients diagnosed with advanced melanoma.
3:00 | 03/24/14

Coming up in the next {{countdown}} {{countdownlbl}}

Coming up next:

{{nextVideo.title}}

{{nextVideo.description}}

Skip to this video now

Now Playing:

{{currentVideo.title}}

More information on this video
Enhanced full screen
Explore related content
Comments
Related Extras
Related Videos
Video Transcript
Transcript for Experimental Drugs Offer New Hope for Patients Fighting Melanoma
I have are asking. 83. Behind the headline here is not working on -- tonight the story about new melanoma drugs and this is why you should care. Melanoma is the the deadliest form of skin cancer kills about 900 people each here. -- -- most at the end stages without treatment average survival is just months this is important also comes to him and his plan. It's cancer killers Virginia when it is clearly an important issue that our story tonight. Is about hope because the major pharmaceutical companies are working on new drugs to fight -- that would change the course of treatment. They're hoping -- the next eighteen months or so here's how it work. It's what's known as it you know there basically you're -- that healthy immune system fight off cancer cells. The trials and -- promised action and 40% of cases they managed to make. -- tumors shrink. So this is really -- about him but experts we spoke to. Stressed that early detection is key exit through -- -- should note check your body well paying marks. And -- -- places like underneath your -- places like that. That's that's coming out thanks for these headlines are -- -- -- -- -- not via Twitter. Mark.

This transcript has been automatically generated and may not be 100% accurate.

{"id":23043287,"title":"Experimental Drugs Offer New Hope for Patients Fighting Melanoma","duration":"3:00","description":" An experimental drug uses the body's immune system to help target tumor cells in patients diagnosed with advanced melanoma. ","section":"GMA","mediaType":"Yahoo Only"}